Abstract:To compare canine decellularized venous valve stent combining endothelial progenitor cells (EPC) with native venous valve in terms of venous valve closure mechanism in normal physiological conditions.Thirty-six male hybrid dogs weighing 15-18 kg were used. The left femoral vein with valve from 12 dogs was harvested to prepare decellularized valved venous stent combined with EPC. The rest 24 dogs were randomly divided into the experimental group and the control group (n=12 per group). In the experimental group, EPC obtained from the bone marrow through in vitro amplification were cultured, the cells at passage 3 (5 x 10(6) cells/mL) were seeded on the stent, and the general and HE staining observations were performed before and after the seeding of the cells. In the experimental group, allogenic decellularized valved venous stent combined with EPC was transplanted to the left femoral vein region, while in the control group, the autogenous vein venous valve was implanted in situ. Color Doppler Ultrasound exam was performed 4 weeks after transplantation to compare the direction and velocity of blood flow in the distal and proximal end of the valve, and the changes of vein diameter in the valve sinus before and after the closure of venous valve when the dogs changed from supine position to reverse trendelenburg position.General and HE staining observations before and after cell seeding: the decellularized valved venous stent maintained its fiber and collagen structure, and the EPC were planted on the decellularized stent successfully through bioreactor. During the period from the reverse trendelenburg position to the starting point for the closure of the valve, the reverse flow of blood occurred in the experimental group with the velocity of (1.4 +/- 0.3) cm/s; while in the control group, there was no reverse flow of blood, but the peak flow rate was decreased from (21.3 +/- 2.1) cm/s to (18.2 +/- 3.3) cm/s. In the control group, the active period of valve, the starting point for the closure of the valve, and the time between the beginning of closure and the complete closure was (918 +/- 46), (712 +/- 48), and (154 +/- 29) ms, respectively; while in the experimental group, it was (989 +/- 53), (785 +/- 43), and (223 +/- 29) ms, respectively. There was significant difference between two groups (P < 0.05). After the complete closure of valve, no reverse flow of blood occurred in two groups. The vein diameter in the valve sinus of the experimental and the control group after the valve closure was increased by 116.8% +/- 2.0% and 118.5% +/- 2.2%, respectively, when compared with the value before valve closure (P > 0.05).Canine decellularized venous valve stent combined with EPC is remarkably different from natural venous valve in terms of the valve closure mechanism in physiological condition. The former relies on the reverse flow of blood and the latter is related to the decreased velocity of blood flow and the increased pressure of vein in the venous sinus segment.

Comparison between canine decellularized venous valve stent combined with endothelial progenitor cells and native venous valve on venous valve closure mechanism in normal physiological conditions]

Can Endothelial Seeding Enhance Patency and Inhibit Neointimal Hyperplasia? Experimental Studies and Clinical Trial of Endothelial Seeded Venous Prostheses

Induction of Differentiation of CD34+ Cells in Vitro and Application in Endothelialization of Blood Vessel Prostheses

Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients with Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair

Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Functional Analysisin Vivoof Engineered Valved Venous Conduit with Decellularized Matrix and Two Bone Marrow-Derived Progenitors in Sheep

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Study on Restoration of Canine Femoral Arteries with Allogenic Veins Pretreated by Polyepoxy Compounds

Bioprosthetic Heart Valves with Reduced Immunogenic Residuals Using Vacuum-Assisted Decellularization Treatment.

Effects of Eptfe Cuff on Arterialization of Implanted Vein in Dogs

Pathological study on the opening of contralateral iliac vein covered by iliac venous stent implantation

Using Decellularized Bovine Jugular Vein to Construct Valved Conduits in Vivo.

Percutaneous pulmonary valve replacement:an experimental study in dogs

Experimental Research on Endothelialization of Artificial Blood Vessel Seeded by Dogs'Bone Marrow Differentiated Cells

Biocompatibility Evaluation of Tissue-Engineered Valved Venous Conduit by Reseeding Autologous Bone Marrow-Derived Endothelial Progenitor Cells and Multipotent Adult Progenitor Cells into Heterogeneous Decellularized Venous Matrix.

Study on Vascular Transplantation with Small-Caliber Decellularized Matrix Vascular Grafts

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Study on small diameter artificial vascular graft with eNOS gene transfected endothelial cells in canine

Reconstruction of the Right Ventricular Outflow Tract with a Treated Bovine Jugular Vein Conduit in Canine